Soluble lymphotoxin is an important effector molecule in GVHD and GVL.

Tumor necrosis factor (TNF) is a key cytokine in the effector phase of graft-versus-host disease (GVHD) after bone marrow transplantation, and TNF inhibitors have shown efficacy in clinical and experimental GVHD. TNF signals through the TNF receptors (TNFR), which also bind soluble lymphotoxin (LTal...

Full description

Bibliographic Details
Main Authors:	Markey, K, Burman, A, Banovic, T, Kuns, R, Raffelt, N, Rowe, V, Olver, S, Don, A, Morris, E, Pettit, A, Wilson, Y, Robb, R, Randall, L, Korner, H, Engwerda, C, Clouston, A, Macdonald, K, Hill, G
Format:	Journal article
Language:	English
Published:	2010

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.

Similar Items